Hints and tips:
Related Special Reports
...CD&R said Lewis, who spent almost three decades at consumer goods group Unilever, will help source and execute deals as well as support its portfolio of companies across Europe....
...Over the past 10 years the size of its buyback scheme dwarfs both its R&D spend and the buyback schemes from peers, adding up to a total of $658bn, according to data from S&P Global....
...The government should give more support to encourage capital expenditure and research and development, said Barnes, whose company makes parts for high performance “hypercars”, top of the range luxury sports...
...The annual jamboree is produced by Jay-Z’s entertainment company Roc Nation. The R&B singer has the stature for the marquee event....
...However, Microsoft and Apple have some of the lowest dividend payouts in the S&P 500 compared with their relative weight to the index....
...He said “nothing was coming out of the business” and no proceeds from the deal would go back to CD&R....
...That compares with 6.8 per cent at Volkswagen, on S&P Capital IQ estimates. Being big also means that necessary investments, in new models and R&D, are less of a drag....
...at which loss-making companies are taxed within the merged scheme from 25 per cent to 19 per cent and lower the threshold for the additional support for R&D intensive lossmaking firms....
...For instance, just one tech company’s recent gains added the equivalent of the market capitalization of the bottom 100 companies in the S&P 500, and the size of the crypto market doubled since last fall....
...Half of the $18.7bn spent on R&D to tackle priority diseases between 2014 and 2022 was provided by the US government....
...Among those with the biggest potential are eczema treatment amlitelimab and multiple sclerosis drug frexalimab. The company spent €6.7bn on R&D last year....
...Subdued consumer demand, rising wages and high interest rates, which hurt more indebted companies, had all contributed to the increase in the number of companies struggling to repay their debt, S&P said....
...M&S’s contract with HSBC, which owns M&S Bank, is up for renewal. M&S is likely to push for more control and a bigger cut of the spoils....
...Walmart was the second-worst performer on the benchmark S&P 500 in the afternoon in New York, falling more than 8 per cent....
...Stellantis’ announcement followed a meeting between executives and the leftist leader, the company said....
...Subdued consumer demand, higher wages in tight labour markets and high interest rates — which hurt more indebted companies — are among the main causes of the increase, according to S&P....
...Vandevelde, 73, is presently a director at the company and will replace chief executive Fabien Simon at the start of April on an interim basis and lead a search for a new CEO....
...Half a dozen of the index’s biggest companies by market capitalisation closed at record highs....
...Those benefits, known as name, image and likeness (NIL) compensation, allow companies to sponsor athletes for product marketing, and indeed some stars have made millions....
...Year-to-date things are looking only slightly better, with US equity long/short hedge funds trailing the S&P 500’s continued surge by about one percentage point. That’s all fine....
...S&P is three years on from completing the purchase of analytics group IHS Markit for $44bn and chief executive Doug Peterson told analysts earlier this month that the company was open to “tuck-in acquisitions...
...One reason for the modest outlook, Buffett writes, is that his company is so big now — 6 per cent of the S&P 500’s total shareholders’ equity — that there are no companies in the US or abroad that are (a...
...Advantech launched a software R&D centre in Pune last October and aims to hire hundreds of software engineers....
...Business and consumer confidence also expanded with the closely watched S&P PMI survey indicating private sector activity grew at the fastest pace in eight months in January....
...However, the company’s big recent launches — including Dupixent, Altuviiio and Beyfortus — were done in partnership with other pharma companies, and the perception among many investors is that Sanofi does...
International Edition